Hip surgery pain relief: new nerve block shows promise

NCT ID NCT07023107

Completed Symptom relief Sponsor: Poznan University of Medical Sciences Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a specific nerve block called PENG, using the numbing drug ropivacaine, could reduce surgical stress and pain after total hip replacement. Sixty older adults (ages 60-100) scheduled for hip surgery under spinal anesthesia received either the nerve block or a placebo (salt water). The main goal was to see if the block lowered inflammation markers in the blood and delayed the need for painkillers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ropivacaine
What this could lead to: If it works, this could offer a better way to manage pain after hip replacement, reducing the need for strong opioids.
What could go wrong: This is a small, completed Phase 4 trial with only 60 participants, so results may not apply to everyone. The nerve block is a temporary procedure and does not change the underlying condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIP ARTHROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis, hip

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIP ARTHROPATHY HIP OSTEOARTHRITIS HIP PAIN CHRONIC

Contacts and locations

Locations

Poznan University of Medical Sciences

Poznan, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.